 Leukapheresis
A2 Biotherapeutics
['solid tumor', 'cart,(-cartitude)']
the basecamp-1 study is currently enrolling participants to explore the feasibility of manufacturing a novel #cartcell therapy that targets a key tumor escape mechanism in patients with solid tumors. #asco22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.